99,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
payback
50 °P sammeln
  • Gebundenes Buch

Edited by a team of the world's leading interventionalcardiologists and educators, this new book is created with an eyeto giving the reader a solid, practical, and clinically focusedunderstanding of this important class of drugs, from basic scienceto a clear-headed discussion of complex topics such as combinationtherapies, drug-to-drug interactions, and resistance toantiplatelet agents.
This important new book:
Begins with a concise but thorough discussion of plateletbiology and pathophysiology so that readers understand howantiplatelet agents work and why they produce such a varied
…mehr

Produktbeschreibung
Edited by a team of the world's leading interventionalcardiologists and educators, this new book is created with an eyeto giving the reader a solid, practical, and clinically focusedunderstanding of this important class of drugs, from basic scienceto a clear-headed discussion of complex topics such as combinationtherapies, drug-to-drug interactions, and resistance toantiplatelet agents.

This important new book:

Begins with a concise but thorough discussion of plateletbiology and pathophysiology so that readers understand howantiplatelet agents work and why they produce such a varied rangeof complications, from minor GI upset to potentiallylife-threatening conditions such as neutropenia, a criticalshortage of white blood cells.
Thoroughly covers platelet function testing, including noveltechniques.
Clarifies current best practice regarding the use ofantiplatelet agents in both chronic and acute cardiovasculardisease.
Reviews all types of antiplatelet agents - from aspirinto recently approved drugs - including indications, clinicaloutcomes, and side effects.

Written by an international "who's who" ofexperts in the field, Antiplatelet Therapy in CardiovascularDisease also includes an entire section covering the use ofantiplatelet drugs in PCIs, including percutaneous valve repair,which makes this text particularly essential to interventionalcardiologists.
Autorenporträt
Ron Waksman, MD, FACC, is Associate Director, Division of Cardiology and Director of Experimental Angioplasty & New Technologies, Washington Hospital Center, Washington, DC. Dr. Waksman is currently the Editor-in-Chief of Cardiovascular Revascularization Medicine and sits on the editorial boards of six other internationally published journals. He has been Editor/Co-Editor of six books since 1996 and has authored 22 additional book chapters. Dr. Waksman has also authored/co-authored over 250 published manuscripts and over 200 abstracts. He is also a Clinical Professor of Medicine (Cardiology) at Georgetown University, Washington, DC, USA.
Rezensionen
"Written by an international who's-who of experts in the field, Antiplatelet Therapy also includes an entire section covering the use of antiplatelet drugs in PCIs, including percutaneous valve repair, which makes this text particularly essential to Interventional Cardiologists." (Kingbook73's Medical Ebook and Video Collection, 20 August 2014)